Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Nothing makes you feel more vulnerable at work than sharing a life-altering health diagnosis, especially as a leader who is ...
Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness
Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...
Accenture CEO Julie Sweet diagnosed with cancer, to undergo surgery next week
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable ...
Accenture CEO diagnosed with breast cancer, to undergo surgery next week
However, the CEO will continue to look after the day-to-day operations of the IT services and consulting firm during the ...
ARN23h
US tech company DEI rollbacks on ‘collision course’ with Aussie govt contracts
The global nature of US technology companies means that changes in their diversity policies to meet executive and legal ...
Fortune 500 giants like Meta and Target are rolling back DEI—These are the policies they’re changing
Just a few years ago, major companies ostentatiously adopted diversity, equity, and inclusion initiatives in response to the ...
Meet CEO of one of world's biggest IT firms, who will undergo treatment for breast cancer
Julie Sweet, Chief Executive Officer of Accenture has recently been diagnosed with early-stage breast cancer and will undergo the treatment for about 12-16 weeks.